Table 1.
Clinical characteristics
| Overall (n = 80) | MCRSP + a (n = 33) | MCRSP – (n = 47) | p | |
|---|---|---|---|---|
| Age (year) | 79 ± 10 | 79 ± 9 | 80 ± 10 | 0.72 |
| Male gender | 63% (50) | 64% (21) | 62% (29) | 0.86 |
| Heart rate (bpm) | 70 ± 12 | 72 ± 14 | 70 ± 11 | 0.52 |
| Systolic blood pressure (mmHg) | 116 ± 18 | 119 ± 18 | 113 ± 17 | 0.17 |
| Diastolic blood pressure (mmHg) | 65 ± 12 | 64 ± 13 | 66 ± 10 | 0.59 |
| Atherosclerosis Risk Factors | ||||
| Hypertension | 81% (65) | 88% (29) | 77% (36) | 0.20 |
| Hypercholesterolemia | 66% (53) | 61% (20) | 70% (33) | 0.37 |
| Diabetes mellitus | 29% (23) | 39% (13) | 21% (10) | 0.08 |
| Tobacco use | 61% (49) | 55% (18) | 66% (31) | 0.30 |
| Coronary Artery Disease | 54% (43) | 52% (17) | 55% (26) | 0.74 |
| Prior Myocardial Infarction | 26% (21) | 21% (7) | 30% (14) | 0.39 |
| Prior Revascularization | 41% (33) | 39% (13) | 43% (20) | 0.78 |
| Atrial fibrillation/flutter | 39% (31) | 39% (13) | 38% (18) | 0.92 |
| Cardiovascular Medications | ||||
| Beta-blocker | 79% (63) | 82% (27) | 77% (36) | 0.57 |
| ACE-Inhibitor/Angiotensin Receptor Blocker | 56% (45) | 52% (17) | 60% (28) | 0.47 |
| Loop diuretic | 81% (65) | 85% (28) | 79% (37) | 0.49 |
| HMG CoA-Reductase Inhibitor | 69% (55) | 70% (23) | 68% (32) | 0.88 |
| Aspirin | 59% (47) | 52% (17) | 64% (30) | 0.27 |
| Number of Clips Implanted | ||||
| Mean | 1.63 ± 0.58 | 1.61 ± 0.50 | 1.64 ± 0.64 | 0.81 |
| Multiple (> 1) | 46 (57%) | 20 (61%) | 26 (55%) | 0.64 |
aOptimal MCRSP defined as ≤ mild MR after MitraClip